Director/PDMR Shareholding

RNS Number : 4999T

Kromek Group PLC

13 October 2017

 

13 October 2017

Kromek Group plc

("Kromek" or the "Company" or the "Group")

Director/PDMR Shareholding

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has received notification that, on 9 October 2017, Sir Peter Williams, Chairman of Kromek, purchased 20,000 Ordinary Shares of 1 pence each ("Ordinary Shares") in the Company at a price of 24.75 pence per share.

Following the purchase, Sir Peter has an interest in 100,000 Ordinary Shares, representing 0.04% of the entire current issued share capital of the Company.

Enquiries:

Kromek Group plc	[phone]
Arnab Basu, CEO Derek Bulmer, CFO
Cenkos Securities plc	[phone]
Bobbie Hilliam (NOMAD) Julian Morse (Sales)
Luther Pendragon Ltd	[phone]
Harry Chathli, Claire Norbury, Alexis Gore

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Sir Peter Williams
2	Reason for the notification
a)	Position/status	Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Kromek Group plc
b)	LEI	N/a
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each GB00BD7V5D43
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 24.75p 20,000
d)	Aggregated information - Aggregated volume - Price	20,000 Ordinary Shares 24.75p per Ordinary Share
e)	Date of the transaction	9 October 2017
f)	Place of the transaction	London Stock Exchange

About Kromek Group plc

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

END

 

 

DSHOKBDQKBDBDKD